Sarepta Therapeutics (SRPT) Tops Q4 EPS by 36c
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Join SI Premium – FREE
Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 EPS of $1.90, $0.36 better than the analyst estimate of $1.54. Revenue for the quarter came in at $658.4 million versus the consensus estimate of $589.45 million.
For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Acuity Brands (AYI) Tops Q3 EPS by 15c
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
